July 4, 2003 (Washington, DC) – Cancer survivor and Tour de France champion Lance Armstrong is partnering with Bristol-Myers Squibb Company for an unprecedented week-long, 3,000 mile journey across the country from October 11-18, called the Tour of Hope. Armstrong will lead 20 cyclists touched by cancer to inspire and inform the public about the importance of cancer research.
Armstrong is seeking 20 riders in the cancer community – survivors, physicians, nurses, caregivers, researchers or loved ones – to join the Tour of Hope team. Riders must possess the cycling ability, physical endurance, and passionate commitment to supporting cancer research. As they spin across America, team members will share their cancer experiences and encourage people to make the Cancer Promise, a personal commitment to learn about cancer and the vital importance of cancer research.
In addition, the Tour of Hope needs 1,500 cyclists to participate in cancer research fund-raising rides of 62.5 miles/100k in Los Angeles, to kick off the Tour of Hope, and a 35- to 45-mile ride in Washington, D.C. to welcome the cross-country riders as they conclude their journey. The Los Angeles ride takes place on Sat., Oct. 11 and the Washington, D.C. ride is on Sat., Oct. 18. All funds raised will benefit the Lance Armstrong Foundation and cancer research community programs. Visit www.tourofhope.org for more information and registration.
Cancer is a disease that touches nearly everyone. Three out of every four American families will have at least one family member diagnosed with cancer. For decades, scientists have been searching for answers to unlock the mysteries of the disease. Today, more than 400 potential new treatments are waiting to be studied. However, the search for a cure is being slowed due to the less than five percent of adults who know cancer research studies are a treatment option and participate in them.
To learn more about the Tour of Hope, apply for a spot on the Tour of Hope Team, make the Cancer Promise, and read the first chapter of LanceÃs new book, visit www.tourofhope.org.
Bristol-Myers Squibb Oncology is dedicated to the discovery, development and exhaustive exploration of innovative cancer fighting therapies that extend and enhance the lives of patients living with cancer. More than 40 years ago, Bristol-Myers Squibb built a unified vision for the future of cancer treatment. With expertise, dedication, and resolve, that vision led to the development of a diverse global portfolio of anti-cancer therapies that are today's cornerstone of care.
Bristol-Myers Squibb is a global pharmaceutical and related health care products company whose mission is to extend and enhance human life.